Di-n-butyl phthalate (DBP)

DBP entered commercial use in the 1930s alongside other phthalate esters developed to keep plastics pliable and prevent cracking [1]. For decades it was a standard ingredient in nail lacquer, hair spray, and the enteric coatings on pharmaceutical tablets that delay release until they reach the intestine [2]. Regulatory scrutiny began in the late 1990s when Danish researchers found DBP in human urine and linked it to declining sperm counts observed across industrialized countries. The European Union banned DBP from toys and childcare articles in 2005 and later from cosmetics; the U.S. Consumer Product Safety Commission banned it from children's products in 2008 [1]. Despite restrictions, DBP persists in many imported products, food packaging adhesives, and some pharmaceuticals, making it one of the most frequently detected phthalates in biomonitoring studies [2].

Nail polish and cosmetics remain the highest-exposure personal care source for adults, especially women who apply nail products regularly [1]. Food contact is significant: DBP migrates from packaging adhesives and PVC films into fatty, acidic, or high-temperature foods [2]. Pharmaceutical enteric coatings on supplements and prescription drugs can deliver meaningful oral doses. Dermal absorption from scented lotions and some vinyl flooring is documented [1]. House dust containing DBP from degraded plastics is inhaled and ingested, particularly by young children. Occupational exposure occurs in pharmaceutical manufacturing, plastics production, and nail salon work [2].

DBP is metabolized to monobutyl phthalate (MBP), which binds androgen receptor pathways and suppresses testosterone synthesis in Leydig cells of the testes [1]. In male rodents, gestational exposure causes 'phthalate syndrome' — undescended testes, hypospadias, and reduced anogenital distance — at doses relevant to human exposure [2]. Epidemiological studies link higher urinary MBP in pregnant women to altered anogenital distances in male infants and lower testosterone in adult men [1]. Female reproductive effects include altered ovarian follicle development. DBP also acts as a thyroid disruptor and has been associated with increased allergic inflammation [2].

Pregnant women are the most critical group: fetal male reproductive development is especially sensitive during the first trimester window when androgen signaling programs genital anatomy [1]. Women who use nail products daily have measurably higher DBP metabolite levels; nail salon workers face continuous occupational inhalation [2]. Infants and toddlers absorb DBP through hand-to-mouth contact with vinyl toys and dust. Men of reproductive age with high DBP exposure show associations with reduced semen quality [1]. People taking enteric-coated medications or supplements containing DBP-based coatings receive direct oral doses [2].

1. Choose nail polishes labeled '3-free,' '5-free,' or '10-free' — these formulas exclude DBP, toluene, and formaldehyde [1]. 2. Open windows when applying nail polish and use a fan; DBP vapors concentrate indoors. 3. Read supplement and medication ingredient lists; ask your pharmacist if enteric coatings contain phthalates and request alternatives if available [2]. 4. Reduce PVC food packaging: opt for glass, stainless steel, or paper packaging especially for fatty or acidic foods. 5. Vacuum regularly with a HEPA-filter vacuum to reduce DBP-laden house dust [1]. 6. Wash hands before eating and after handling plastic packaging, and mop hard floors to reduce dust ingestion by crawling children [2].